| Stage | AMGN | % of rev | ADMA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $10.4B | 100.00% | $124M | 100.00% | AMGN ×83.32 |
| Gross profit | $7.6B | 73.10% | $86M | 69.36% | AMGN +3.7pp |
| Operating income | $3.7B | 35.79% | $52M | 42.16% | ADMA +6.4pp |
| Pre-tax income | $4.7B | 45.21% | $50M | 40.39% | AMGN +4.8pp |
| Net income | $3.9B | 37.28% | $38M | 30.40% | AMGN +6.9pp |
| Stage | AMGN | ADMA | Gap · A − B |
|---|---|---|---|
| Revenue | $10.4B100.00% | $124M100.00% | AMGN ×83.32 |
| Gross profit | 73.10%$7.6B | 69.36%$86M | AMGN +3.7pp |
| Operating income | 35.79%$3.7B | 42.16%$52M | ADMA +6.4pp |
| Pre-tax income | 45.21%$4.7B | 40.39%$50M | AMGN +4.8pp |
| Net income |
| 37.28%$3.9B |
| 30.40%$38M |
| AMGN +6.9pp |
No shared counterparties.